scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...987611J |
P356 | DOI | 10.1371/JOURNAL.PONE.0087611 |
P932 | PMC publication ID | 3914812 |
P698 | PubMed publication ID | 24505294 |
P5875 | ResearchGate publication ID | 260127101 |
P50 | author | Shawn D. Aaron | Q41542409 |
Craig Winstanley | Q42686188 | ||
P2093 | author name string | Roger C Levesque | |
Nicholas P Tucker | |||
Joanne L Fothergill | |||
Brian Boyle | |||
Irena Kukavica-Ibrulj | |||
Julie Jeukens | |||
Steve J Charette | |||
Myriam M Ouellet | |||
P2860 | cites work | Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. | Q51711090 |
Decreased virulence of cystic fibrosis Pseudomonas aeruginosa in Dictyostelium discoideum. | Q51890204 | ||
A Subtype of aPseudomonas aeruginosaCystic Fibrosis Epidemic Strain Exhibits Enhanced Virulence in a Murine Model of Acute Respiratory Infection | Q59417555 | ||
Infection With Transmissible Strains of Pseudomonas aeruginosa and Clinical Outcomes in Adults With Cystic Fibrosis | Q59465404 | ||
Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model | Q82526777 | ||
Dictyostelium discoideum: a model host to measure bacterial virulence | Q83162103 | ||
Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs | Q83862019 | ||
Complex Pseudomonas population structure in cystic fibrosis airway infections | Q84411097 | ||
Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. | Q39653993 | ||
The rpoN gene product of Pseudomonas aeruginosa is required for expression of diverse genes, including the flagellin gene | Q39943644 | ||
Complete genome sequences of three Pseudomonas aeruginosa isolates with phenotypes of polymyxin B adaptation and inducible resistance | Q40346806 | ||
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. | Q41091925 | ||
A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. | Q42604401 | ||
xBASE2: a comprehensive resource for comparative bacterial genomics. | Q43032299 | ||
Complete Genome Sequence of Persistent Cystic Fibrosis Isolate Pseudomonas aeruginosa Strain RP73. | Q43063469 | ||
Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations. | Q43216747 | ||
Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections | Q43593080 | ||
Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence | Q43608975 | ||
Lysophosphatidic acid inhibition of the accumulation of Pseudomonas aeruginosa PAO1 alginate, pyoverdin, elastase and LasA. | Q44021551 | ||
Comparing thousands of circular genomes using the CGView Comparison Tool | Q21266705 | ||
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen | Q22122393 | ||
Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes | Q24609340 | ||
Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa | Q24676026 | ||
Basic local alignment search tool | Q25938991 | ||
Consed: a graphical tool for sequence finishing | Q27860740 | ||
Two-component signal transduction | Q28145002 | ||
Pseudomonas aeruginosa Genomic Structure and Diversity | Q28244678 | ||
Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa | Q28492507 | ||
A two-component response regulator, gltR, is required for glucose transport activity in Pseudomonas aeruginosa PAO1 | Q28492607 | ||
Cloning and phenotypic characterization of fleS and fleR, new response regulators of Pseudomonas aeruginosa which regulate motility and adhesion to mucin | Q28492811 | ||
Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases | Q28492998 | ||
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia | Q29615286 | ||
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients | Q29615301 | ||
Sequencing intractable DNA to close microbial genomes | Q31079752 | ||
Intraclonal genome diversity of Pseudomonas aeruginosa clones CHA and TB | Q31121749 | ||
Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain | Q33285539 | ||
Pan-genome sequence analysis using Panseq: an online tool for the rapid analysis of core and accessory genomic regions | Q33693333 | ||
Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist | Q34019954 | ||
Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. | Q34135036 | ||
Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzyme | Q34189506 | ||
Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system | Q34311932 | ||
Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. | Q34483463 | ||
Persistent and aggressive bacteria in the lungs of cystic fibrosis children. | Q34628960 | ||
Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. | Q34661901 | ||
Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database | Q34849651 | ||
Evolutionary dynamics of bacteria in a human host environment | Q34937408 | ||
VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. | Q35631089 | ||
Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis | Q35773317 | ||
Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa | Q37401403 | ||
Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa | Q37421177 | ||
Toward a general theory of adaptive radiation: insights from microbial experimental evolution | Q37536208 | ||
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)--a cause for concern? | Q37965336 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Pseudomonas aeruginosa | Q31856 |
epidemic | Q44512 | ||
comparative genomics | Q1147112 | ||
cystic fibrosis | Q178194 | ||
P304 | page(s) | e87611 | |
P577 | publication date | 2014-02-05 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients | |
P478 | volume | 9 |
Q64115099 | Accessory genome of the multi-drug resistant ocular isolate of Pseudomonas aeruginosa PA34 |
Q31082168 | Application of Whole-Genome Sequencing Data for O-Specific Antigen Analysis and In Silico Serotyping of Pseudomonas aeruginosa Isolates |
Q35746038 | Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58. |
Q37105133 | Bile signalling promotes chronic respiratory infections and antibiotic tolerance |
Q31008319 | Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium |
Q57799883 | Comparative genomics of clinical strains of Pseudomonas aeruginosa strains isolated from different geographic sites |
Q95276755 | Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities |
Q35530910 | Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections |
Q37492055 | Do Bacterial "Virulence Factors" Always Increase Virulence? A Meta-Analysis of Pyoverdine Production in Pseudomonas aeruginosa As a Test Case |
Q33911762 | Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone |
Q38417030 | Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients |
Q40737567 | Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients. |
Q35744602 | Genes Required for Free Phage Production are Essential for Pseudomonas aeruginosa Chronic Lung Infections. |
Q35797154 | Genetically and Phenotypically Distinct Pseudomonas aeruginosa Cystic Fibrosis Isolates Share a Core Proteomic Signature |
Q41614230 | Genome-wide patterns of recombination in the opportunistic human pathogen Pseudomonas aeruginosa |
Q44842487 | Genomic characterization of a local epidemic Pseudomonas aeruginosa reveals specific features of the widespread clone ST395. |
Q30278439 | Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains |
Q37367535 | Iminoguanidines as Allosteric Inhibitors of the Iron-Regulated Heme Oxygenase (HemO) of Pseudomonas aeruginosa |
Q40480159 | Metabolic flux analyses of Pseudomonas aeruginosa cystic fibrosis isolates. |
Q58119825 | Metapopulation Structure of CRISPR-Cas Immunity in and Its Viruses |
Q35892115 | Molybdate transporter ModABC is important for Pseudomonas aeruginosa chronic lung infection |
Q61449168 | Persistence and Microevolution of in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study |
Q26786112 | Phenotypic and Genotypic Characteristics of Small Colony Variants and Their Role in Chronic Infection |
Q92429978 | Potentiation of Aminoglycoside Lethality by C4-Dicarboxylates Requires RpoN in Antibiotic-Tolerant Pseudomonas aeruginosa |
Q38605131 | Potentiation of Tobramycin by Silver Nanoparticles Against Pseudomonas aeruginosa Biofilms. |
Q36018232 | Preliminary feasibility and modelling of a liquid matrix Dictyostelium discoideum virulence assay for Pseudomonas aeruginosa |
Q60044193 | Privatisation rescues function following loss of cooperation |
Q41758615 | Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs |
Q34480377 | Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes |
Q34992254 | Pseudomonas aeruginosa isolates from dental unit waterlines can be divided in two distinct groups, including one displaying phenotypes similar to isolates from cystic fibrosis patients |
Q34906024 | Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection |
Q36324807 | Refined analyses suggest that recombination is a minor source of genomic diversity in Pseudomonas aeruginosa chronic cystic fibrosis infections |
Q35761876 | Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung |
Q34922676 | The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility |
Q108126960 | Transmission, adaptation and geographical spread of the Liverpool epidemic strain |
Q40210470 | Two-component systems required for virulence in Pseudomonas aeruginosa |
Q37082208 | Whole-Genome Sequence of Multidrug-Resistant Pseudomonas aeruginosa Strain BAMCPA07-48, Isolated from a Combat Injury Wound |
Q26799059 | Whole-genome sequencing targets drug-resistant bacterial infections |
Q64117266 | Within-Host Adaptation Mediated by Intergenic Evolution in Pseudomonas aeruginosa |
Q33555304 | Within-Host Evolution of Burkholderia pseudomallei during Chronic Infection of Seven Australasian Cystic Fibrosis Patients |
Q36060289 | Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis. |
Q35813781 | Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients |
Q64448653 | cAMP and Vfr Control Exolysin Expression and Cytotoxicity of Pseudomonas aeruginosa Taxonomic Outliers |
Search more.